Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;45(12):1385-1389.
doi: 10.1111/pace.14565. Epub 2022 Aug 15.

Use of supra-therapeutic phenytoin for management of ventricular arrhythmias in children: Case series and literature review

Suneet Bhansali  1 , Reina Bianca M Tan  1 , Maria Spilios  2 , Frank Cecchin  1
Affiliations
Review

Use of supra-therapeutic phenytoin for management of ventricular arrhythmias in children: Case series and literature review

Suneet Bhansali et al. Pacing Clin Electrophysiol. 2022 Dec.

Abstract

Phenytoin is a versatile drug with utility in neurological, dermatological, and even cardiac disease processes. Though phenytoin is widely available due to its excellent anti-epileptic properties, it is now rarely used as an antiarrhythmic. Phenytoin has well-studied sodium-channel blocking abilities which can be taken advantage of to treat ventricular arrhythmias. Thus, it should remain in the arsenal of antiarrhythmics for any electrophysiologist. We present two cases of intractable ventricular arrhythmia in children that were controlled with phenytoin at supra-therapeutic serum levels, preventing the need for heart transplantation.

Keywords: arrhythmia; electrical storm; long qt; phenytoin; syndrome.

PubMed Disclaimer

Similar articles

See all similar articles

References

REFERENCES

    1. Keppel Hesselink JM, Kopsky DJ. Phenytoin: 80 years young, from epilepsy to breast cancer, a remarkable molecule with multiple modes of action. J Neurol. 2017;264:1617-1621.
    1. Guldiken B, Rémi J, Noachtar S. Cardiovascular adverse effects of phenytoin. J Neurol. 2016;263:861-870.
    1. Jones GL, Wimbish GH, McIntosh WE. Phenytoin: basic and clinical pharmacology. Med Res Rev. 1983;3:383-434.
    1. Tan RB, Chakravarti S, Busovsky-McNeal M, Walsh A, Cecchin F. Complexity of ranolazine and phenytoin use in an infant with long QT syndrome type 3. Hear Case Reports. 2016;3:104-108.
    1. Wit AL, Rosen MR, Hoffman BF. Electrophysiology and pharmacology of cardiac arrhythmias. VIII. Cardiac effects of diphenylhydantoin. B. Am Heart J. 1975;90:397-404.

LinkOut - more resources